A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell...

por MICHAEL, M., PAVLAKIS, N., CLINGAN, P., DE BOER, R., JOHNSTON, M., CLARKE, S.
Publicado 2012

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials

por Segelov, E, Chan, D, Shapiro, J, Price, T J, Karapetis, C S, Tebbutt, N C, Pavlakis, N
Publicado 2014

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

por Linton, A, Pavlakis, N, O'Connell, R, Soeberg, M, Kao, S, Clarke, S, Vardy, J, van Zandwijk, N
Publicado 2014

Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial

por Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Kothe, E., Lam, L., Rosenthal, D.
Publicado 2010

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial

por Tebbutt, N C, Parry, M M, Zannino, D, Strickland, A H, Van Hazel, G A, Pavlakis, N, Ganju, V, Mellor, D, Dobrovic, A, Gebski, V J
Publicado 2013

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians

por Chazan, G., Franchini, F., Alexander, M., Banerjee, S., Mileshkin, L., Blinman, P., Zielinski, R., Karikios, D., Pavlakis, N., Peters, S., Lordick, F., Ball, D., Wright, G., IJzerman, M., Solomon, B.J.
Publicado 2021

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

por Lin, H-M, Castillo, L, Mahon, K L, Chiam, K, Lee, B Y, Nguyen, Q, Boyer, M J, Stockler, M R, Pavlakis, N, Marx, G, Mallesara, G, Gurney, H, Clark, S J, Swarbrick, A, Daly, R J, Horvath, L G
Publicado 2014

Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach

por Gordon, S., Chan, D. L. H., Bernard, E. J., Eslick, M. E., Willowson, K. P., Roach, P. J., Engel, A. F., Maher, R., Clarke, S. J., Agarwal, V., Yasmin, L., De Silva, M., Mascall, S., Conner, A., Nevell, D., Pavlakis, N., Bailey, D. L.
Publicado 2023

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

por Mahon, K L, Lin, H-M, Castillo, L, Lee, B Y, Lee-Ng, M, Chatfield, M D, Chiam, K, Breit, S N, Brown, D A, Molloy, M P, Marx, G M, Pavlakis, N, Boyer, M J, Stockler, M R, Daly, R J, Henshall, S M, Horvath, L G
Publicado 2015